Reactions appeared near injection site at a median onset of day 8 after first dose; six of 12 patients had no recurrence after second dose
Patients’ Mental Health Impacts Rating of Psoriasis Severity
Likelihood of a patient overestimating their psoriasis severity versus physician increased for those with depression, anxiety
Good Response Seen With HealthCare.gov Reopening
CMS figures show more than 206,000 people signed up for coverage from Feb. 15 to 28
Fecal Transplant May Counter Anti-PD-1 Resistance in Melanoma
FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma
Prevalence Data Suggest Increasing Trend of Psoriasis With Age
Worldwide studies suggest stable or slightly decreasing trend in incidence of psoriasis and increasing trend in prevalence
Biomarker May Predict Treatment Outcome in Advanced Melanoma
Changes in plasma levels of ctDNA associated with survival outcomes in BRAF V600 mutation-positive unresectable or metastatic melanoma
Overall Pregnancy, Live Birth Outcomes Unchanged in Psoriasis
Of the births, 90.9 percent born full term, 9.1 percent born prematurely; few had neonatal problem or congenital anomaly
Factors Other Than Workplace Tied to COVID-19 Positivity in HCWs
Demographic, community factors show stronger influence than workplace exposure on COVID-19 risk in health care workers
ICI Need Not Be Withheld in Those With Autoimmune Disease
Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID